TriActive Dental Implant System
Paragon Implant Mfg., LLC · Decision date Sep 17, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K261392, the TriActive Dental Implant System, on 2026-09-17, with the application received 04/29/2026. The applicant is Paragon Implant Mfg., LLC of Calabasas, California, and the device falls under regulation 872.3640 as an endosseous, root-form implant with classification product code DZE and subsequent product code NHA. This is a 510(k) clearance, not a PMA approval.
The record describes the submission as an abbreviated summary reviewed by FDA rather than a third party, and it was not a combination product; no predetermined change control plan was authorized. The available material does not identify the predicate device, the specific components or changes submitted, or any performance data supporting equivalence, so the technical basis for the decision remains unknown from these sources.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Dental
- Decision date
- Sep 17, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261392
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Paragon Implant Mfg., LLC
- Product code
- DZE
- Decision code
- SESE
- Decision date
- Sep 17, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Implant, Endosseous, Root-Form.
- Applicant
- Paragon Implant Mfg., LLC
- Product code
- DZE
- FDA device class
- 2
FDA decision timeline
K261392 received
Application receipt date recorded by FDA.
K261392 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DZE
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Alpha Bio Tec , Ltd. | 510(k) clearance | Oct 22, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Paragon Implant Mfg., LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Calabasas, CA
Sources and methodology
- Original FDA record: K261392
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records